QSS
NEOS

Quantitative Systematic Strategies’s Neos Therapeutics, Inc NEOS Stock Holding History

Quantitative Systematic Strategies’s Portfolio NEOS Stock Details NEOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-14,265
Closed -$69K – 920
2018
Q3 		$69K Buy
14,265
+534
+4% +$3.03K 0.01% 587
2018
Q2 		$86K Sell
13,731
-1,112
-7% -$8.29K 0.02% 598
2018
Q1 		$123K Buy
+14,843
New +$142K 0.03% 592

Other funds holding NEOS

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Quantitative Systematic Strategies's NEOS Position: Q4 2018 in Review

Quantitative Systematic Strategies sold out of Neos Therapeutics, Inc (NEOS) in Q4 2018, closing a stake of 14,265 shares — an estimated $69K sold.

Quantitative Systematic Strategies first reported a position in NEOS in Q1 2018 and held it in 3 quarters. The position peaked at $123K in Q1 2018. 63 funds tracked by Wall St. Rank hold NEOS as of Q4 2018.

  • Quantitative Systematic Strategies reported no remaining Neos Therapeutics, Inc position as of Q4 2018 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 14,265 Neos Therapeutics, Inc shares in Q4 2018, an estimated $69K.
  • Quantitative Systematic Strategies first reported a position in Neos Therapeutics, Inc in Q1 2018 and held it in 3 quarters.
  • Quantitative Systematic Strategies's Neos Therapeutics, Inc position peaked at $123K in Q1 2018.
  • 63 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q4 2018.

Based on Quantitative Systematic Strategies's 13F filing for Q4 2018, filed 12 Feb 2019.